Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2440894
Max Phase: Preclinical
Molecular Formula: C24H36N2O4
Molecular Weight: 416.56
Molecule Type: Small molecule
Associated Items:
ID: ALA2440894
Max Phase: Preclinical
Molecular Formula: C24H36N2O4
Molecular Weight: 416.56
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](NC[C@H](N)C(=O)O)C[C@]12C
Standard InChI: InChI=1S/C24H36N2O4/c1-13(27)17-6-7-18-16-5-4-14-10-15(28)8-9-23(14,2)21(16)20(11-24(17,18)3)26-12-19(25)22(29)30/h10,16-21,26H,4-9,11-12,25H2,1-3H3,(H,29,30)/t16-,17+,18-,19-,20-,21+,23-,24+/m0/s1
Standard InChI Key: YVGKPKBONYGPMB-JNMIDYNYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 416.56 | Molecular Weight (Monoisotopic): 416.2675 | AlogP: 2.70 | #Rotatable Bonds: 5 |
Polar Surface Area: 109.49 | Molecular Species: ZWITTERION | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 2.15 | CX Basic pKa: 10.53 | CX LogP: -0.42 | CX LogD: -0.45 |
Aromatic Rings: 0 | Heavy Atoms: 30 | QED Weighted: 0.64 | Np Likeness Score: 1.93 |
1. Pandya K, Dietrich D, Seibert J, Vederas JC, Odermatt A.. (2013) Synthesis of sterically encumbered 11β-aminoprogesterone derivatives and evaluation as 11β-hydroxysteroid dehydrogenase inhibitors and mineralocorticoid receptor antagonists., 21 (21): [PMID:24074876] [10.1016/j.bmc.2013.08.068] |
Source(1):